CompletedNot Applicable

Long-Term Outcome of Children and Adolescents With Anti-Phospholipid Antibodies

United States110 participantsStarted 2001-05

Plain-language summary

This is a study about why some people have certain types of proteins in their blood, called anti-phospholipid antibodies. The presence of these antibodies and associated complications (e.g. blood clots) are known to change over time. The purpose of this study is to evaluate these changes and improve our ability to determine the long-term outcome of affected individuals.

Who can participate

Age range21 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Age: Less than 21 years at baseline exam * Diagnosis: patients must meet criteria for one of five diagnostic categories based on classification according to three parameters; aPL positivity, APS criteria, and SLE criteria. The five diagnostic categories are: * SLE with no aPL * SLE with aPL, but without manifestations of APS * SLE-like APS * SLE with APS * Primary APS. Exclusion Criteria: * none

What they're measuring

thrombosis

Timeframe: Ten years

Trial details

NCT IDNCT00581763

SponsorUniversity of California, San Francisco

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-12-20

View on ClinicalTrials.gov More Lupus trials